2024 Q3 Form 10-Q Financial Statement
#000121390024095882 Filed on November 08, 2024
Income Statement
Concept | 2024 Q3 |
---|---|
Revenue | |
YoY Change | |
Cost Of Revenue | |
YoY Change | |
Gross Profit | |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | |
YoY Change | |
% of Gross Profit | |
Research & Development | |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | |
YoY Change | |
% of Gross Profit | |
Operating Expenses | |
YoY Change | |
Operating Profit | -$58.40K |
YoY Change | -3.27% |
Interest Expense | |
YoY Change | |
% of Operating Profit | |
Other Income/Expense, Net | $14.48K |
YoY Change | 2.46% |
Pretax Income | -$43.92K |
YoY Change | -5.02% |
Income Tax | $1.640K |
% Of Pretax Income | |
Net Earnings | -$45.56K |
YoY Change | -32.27% |
Net Earnings / Revenue | |
Basic Earnings Per Share | |
Diluted Earnings Per Share | |
COMMON SHARES | |
Basic Shares Outstanding | |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q3 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | |
YoY Change | |
Cash & Equivalents | $1.130M |
Short-Term Investments | |
Other Short-Term Assets | |
YoY Change | |
Inventory | |
Prepaid Expenses | |
Receivables | |
Other Receivables | |
Total Short-Term Assets | |
YoY Change | |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | |
YoY Change | |
Long-Term Investments | |
YoY Change | |
Other Assets | |
YoY Change | |
Total Long-Term Assets | |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | |
Total Long-Term Assets | |
Total Assets | $1.150M |
YoY Change | -6.37% |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | |
YoY Change | |
Accrued Expenses | $195.3K |
YoY Change | -63.49% |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | |
YoY Change | |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $677.3K |
YoY Change | 21.52% |
LONG-TERM LIABILITIES | |
Long-Term Debt | |
YoY Change | |
Other Long-Term Liabilities | |
YoY Change | |
Total Long-Term Liabilities | |
YoY Change | |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $677.3K |
Total Long-Term Liabilities | |
Total Liabilities | $680.3K |
YoY Change | -3.69% |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$563.1K |
YoY Change | 10.21% |
Common Stock | |
YoY Change | |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | $469.8K |
YoY Change | |
Total Liabilities & Shareholders Equity | $1.150M |
YoY Change | -6.37% |
Cashflow Statement
Concept | 2024 Q3 |
---|---|
OPERATING ACTIVITIES | |
Net Income | -$45.56K |
YoY Change | -32.27% |
Depreciation, Depletion And Amortization | |
YoY Change | |
Cash From Operating Activities | |
YoY Change | |
INVESTING ACTIVITIES | |
Capital Expenditures | |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | |
YoY Change | |
Cash From Investing Activities | |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | |
YoY Change | |
NET CHANGE | |
Cash From Operating Activities | |
Cash From Investing Activities | |
Cash From Financing Activities | |
Net Change In Cash | |
YoY Change | |
FREE CASH FLOW | |
Cash From Operating Activities | |
Capital Expenditures | |
Free Cash Flow | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
usd | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
shares | |
CY2024Q3 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
usd | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-39534 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
PMV Consumer Acquisition Corp. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
84-5174573 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
249 Royal Palm Way | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 503 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Palm Beach | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33480 | ||
dei |
City Area Code
CityAreaCode
|
(561) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
318-3766 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1130295 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1072630 | usd |
CY2024Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
19789 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
129474 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
1150084 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
1202104 | usd |
CY2024Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
195278 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
175745 | usd |
CY2023Q4 | us-gaap |
Taxes Payable Current
TaxesPayableCurrent
|
10259 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
677278 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
578004 | usd |
CY2024Q3 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
2980 | usd |
CY2023Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
2980 | usd |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
680258 | usd |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
580984 | usd |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
460000 | shares |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
460000 | shares |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1032917 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
1032917 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-563101 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-411807 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
469826 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
621120 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1150084 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1202104 | usd |
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
50395 | usd |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
57670 | usd |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
148092 | usd | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
201842 | usd | |
CY2024Q3 | pmvcd |
Franchise Tax Expense
FranchiseTaxExpense
|
8000 | usd |
CY2023Q3 | pmvcd |
Franchise Tax Expense
FranchiseTaxExpense
|
2700 | usd |
pmvcd |
Franchise Tax Expense
FranchiseTaxExpense
|
23286 | usd | |
pmvcd |
Franchise Tax Expense
FranchiseTaxExpense
|
10200 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-58395 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-60370 | usd |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-171378 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-212042 | usd | |
CY2024Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
14480 | usd |
CY2023Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
14132 | usd |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
42075 | usd | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
36981 | usd | |
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
14480 | usd |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
14132 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
42075 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
36981 | usd | |
CY2024Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-43915 | usd |
CY2023Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-46238 | usd |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-129303 | usd | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-175061 | usd | |
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1640 | usd |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
21024 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
21991 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
32226 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-45555 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-67262 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-151294 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-207287 | usd | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
621120 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-77383 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
543737 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28356 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
515381 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-45555 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
469826 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
729261 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-98590 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
630671 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-41435 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
589236 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-67262 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
521974 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-151294 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-207287 | usd | |
us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
-42424 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-109685 | usd | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-46989 | usd | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-10259 | usd | |
us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-7774 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
19533 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-14666 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
90000 | usd | |
us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
90000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
57665 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-50314 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
57665 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-50314 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1072630 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1149157 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1130295 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1098843 | usd |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
34000 | usd | |
us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
40000 | usd | |
CY2023Q3 | us-gaap |
Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
|
100000000 | shares |
CY2024Q3 | pmvcd |
Ownership Percentage
OwnershipPercentage
|
0.20 | pure |
CY2024Q3 | us-gaap |
Common Stock Shares Held In Employee Trust
CommonStockSharesHeldInEmployeeTrust
|
154874303 | usd |
CY2024Q3 | pmvcd |
Redemption Common Stock Price Per Share
RedemptionCommonStockPricePerShare
|
10.02 | |
us-gaap |
Interest Expense Trust Preferred Securities
InterestExpenseTrustPreferredSecurities
|
340393 | usd | |
pmvcd |
Aggregate Amount Of Remaining Trust Account
AggregateAmountOfRemainingTrustAccount
|
20511170 | usd | |
CY2022Q4 | pmvcd |
Redeemed Of Cash
RedeemedOfCash
|
42424 | usd |
CY2023Q1 | pmvcd |
Aggregate Purchase Price
AggregatePurchasePrice
|
42000 | shares |
us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
In light of the Class C Conversion, and in order to simplify and better reflect the purpose, capital structure, governance and organizational policies and procedures of the Company, the Board of Directors of the Company (the “Board”) recommended, and the stockholders approved on September 29, 2023, various amendments to the Charter, as well as a reverse stock split of all outstanding shares of Class B convertible common stock and Class C common stock at a ratio of 43.792-to-1 (the “Reverse Stock Split”). | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Use of Estimates</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these unaudited condensed financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates.</p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i><span style="text-decoration:underline">Concentration of Credit Risk</span></i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred, or a lack of access to such funds, could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</p> | ||
us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
250000 | usd | |
us-gaap |
Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
|
On August 3, 2020, the Company effected a 1.4-for-1 forward stock split of its issued and outstanding shares of Class B convertible common stock, resulting in an aggregate of 5,031,250 Founder Shares being outstanding, of which an aggregate of up to 656,250 shares were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. | ||
CY2020Q3 | us-gaap |
Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
|
656250 | shares |
CY2020Q3 | pmvcd |
Shares Conversion Ration Percentage
SharesConversionRationPercentage
|
0.20 | pure |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
42000 | usd |
CY2020Q3 | us-gaap |
Related Party Tax Expense Due To Affiliates Current
RelatedPartyTaxExpenseDueToAffiliatesCurrent
|
10000 | usd |
CY2024Q3 | us-gaap |
Payment For Administrative Fees
PaymentForAdministrativeFees
|
30000 | usd |
CY2023Q3 | us-gaap |
Payment For Administrative Fees
PaymentForAdministrativeFees
|
30000 | usd |
us-gaap |
Payment For Administrative Fees
PaymentForAdministrativeFees
|
90000 | usd | |
us-gaap |
Payment For Administrative Fees
PaymentForAdministrativeFees
|
90000 | usd | |
CY2024Q3 | us-gaap |
Investment Company Market Value Per Share
InvestmentCompanyMarketValuePerShare
|
1 | |
pmvcd |
Underwriting Deferred Fee
UnderwritingDeferredFee
|
0.35 | ||
us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
6125000 | usd | |
CY2022Q3 | pmvcd |
Deferred Underwriting Commission
DeferredUnderwritingCommission
|
4593750 | usd |
CY2022Q4 | pmvcd |
Forfeiture Remaining Deferred Underwriting Fee
ForfeitureRemainingDeferredUnderwritingFee
|
1531250 | usd |
CY2022 | pmvcd |
Deferred Underwriting Fee Payable
DeferredUnderwritingFeePayable
|
6125000 | usd |
CY2022Q4 | pmvcd |
Forgiveness Of The Deferred Underwriting Fee Allocated To Public Shares
ForgivenessOfTheDeferredUnderwritingFeeAllocatedToPublicShares
|
5815688 | usd |
CY2022 | pmvcd |
Gain From Extinguishment Of Liability Allocated To Warrant Liabilities
GainFromExtinguishmentOfLiabilityAllocatedToWarrantLiabilities
|
309312 | usd |
us-gaap |
Class Of Warrant Or Right Reason For Issuing To Nonemployees
ClassOfWarrantOrRightReasonForIssuingToNonemployees
|
●in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption; ● if, and only if, the reported last sale price of the Company’s common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and subject to adjustment as described below) for any 20 trading days within a 30-trading day period ending on the third business day prior to the notice of redemption to the warrant holders; and ● If, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying the warrants. | ||
pmvcd |
Warrant Price
WarrantPrice
|
0.01 | ||
us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
18 | ||
CY2024Q3 | pmvcd |
Shares Outstanding Percentage
SharesOutstandingPercentage
|
1 | pure |
CY2023Q4 | us-gaap |
Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
|
100000 | shares |
CY2024Q3 | us-gaap |
Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
|
432880 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
|
401781 | usd |
CY2024Q3 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
432880 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
401781 | usd |
CY2024Q3 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
432880 | usd |
CY2023Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
401781 | usd |
CY2024Q3 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
1280 | usd |
CY2023Q3 | us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
8077 | usd |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
19400 | usd | |
us-gaap |
Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
|
8627 | usd | |
CY2024Q3 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-10583 | usd |
us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
-31099 | usd | |
CY2024Q3 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
360 | usd |
CY2023Q3 | us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
12947 | usd |
us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
2591 | usd | |
us-gaap |
Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
|
23599 | usd | |
CY2024Q3 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
10583 | usd |
us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
31099 | usd | |
CY2024Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
1640 | usd |
CY2023Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
21024 | usd |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
21991 | usd | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
32226 | usd | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.02 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
|
-0.135 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
-0.12 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
|
-0.259 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
-0.241 | pure | |
us-gaap |
Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
0 | pure | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.17 | pure | |
us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
-0.184 | pure | |
CY2024Q3 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false | |
CY2024Q3 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q3 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
usd | ||
CY2024Q3 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
|
usd | |
CY2024Q3 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2023Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
usd | |
CY2023Q3 | us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
|
usd | ||
CY2024Q3 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
CY2023Q3 | us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | |
us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | ||
us-gaap |
Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
|
usd | ||
CY2023Q3 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
usd | |
us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
usd | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001807765 |